Colorectal Cancer Screening
Open Access
- 12 March 2003
- journal article
- review article
- Published by American Medical Association (AMA) in JAMA
- Vol. 289 (10), 1288-1296
- https://doi.org/10.1001/jama.289.10.1288
Abstract
Review from JAMA — Colorectal Cancer Screening — Scientific Review — ContextScreening for colorectal cancer clearly reduces colorectal cancer mortality, yet many eligible adults remain unscreened. Several screening tests are available, and various professional organizations have differing recommendations on which screening test to use. Clinicians are challenged to ensure that eligible patients undergo colorectal cancer screening and to guide patients in choosing what tests to receive.ObjectiveTo critically assess the evidence for use of the available colorectal cancer screening tests, including fecal occult blood tests, sigmoidoscopy, colonoscopy, double-contrast barium enema, and newer tests, such as virtual colonoscopy and stool-based molecular screening.Data SourcesAll relevant English-language articles were identified using PubMed (January 1966-August 2002), published meta-analyses, reference lists of key articles, and expert consultation.Data ExtractionStudies that evaluated colorectal cancer screening in healthy individuals and assessed clinical outcomes were included. Evidence from randomized controlled trials was considered to be of highest quality, followed by observational evidence. Diagnostic accuracy studies were evaluated when randomized controlled trials and observational studies were not available or did not provide adequate evidence. Studies were excluded if they did not evaluate colorectal screening tests and if they did not evaluate average-risk individuals.Data SynthesisRandomized controlled trials have shown that fecal occult blood testing can reduce colorectal cancer incidence and mortality. Case-control studies have shown that sigmoidoscopy is associated with a reduction in mortality, and observational studies suggest colonoscopy is effective as well. Combining fecal occult blood testing and sigmoidoscopy may decrease mortality and can increase diagnostic yield.ConclusionThe recommendation that all men and women aged 50 years or older undergo screening for colorectal cancer is supported by a large body of direct and indirect evidence. At present, the available evidence does not currently support choosing one test over another.Keywords
This publication has 98 references indexed in Scilit:
- Guidelines for training non-specialists in screening flexible sigmoidoscopyGastrointestinal Endoscopy, 2000
- Virtual Colonoscopy — Promising, but Not Ready for Widespread UseNew England Journal of Medicine, 1999
- A Comparison of Virtual and Conventional Colonoscopy for the Detection of Colorectal PolypsNew England Journal of Medicine, 1999
- Importance of Adenomas 5 mm or Less in Diameter That Are Detected by SigmoidoscopyNew England Journal of Medicine, 1997
- Randomised study of screening for colorectal cancer with faecal-occult-blood testThe Lancet, 1996
- Randomised controlled trial of faecal-occult-blood screening for colorectal cancerThe Lancet, 1996
- Neoplasia distal to the splenic flexure in patients with proximal colon cancerGastrointestinal Endoscopy, 1996
- Prospective blinded trial of the colonoscopic miss-rate of large colorectal polypsGastrointestinal Endoscopy, 1991
- Performing screening flexible sigmoidoscopy using colonoscopes: experience in 500 subjectsGastrointestinal Endoscopy, 1990
- Flexible fiberoptic sigmoidoscopy training for primary care physicians: results of a 5-year experienceGastrointestinal Endoscopy, 1989